Roivant's latest biotech company launch – Pulmovant – has made its debut with a plan to develop a respiratory drug licensed from Bayer in a deal worth up to $294 million. Pulmovant is tasked ...

After his stint as head coach of Ajax Amsterdam, John van’t Schip is back in the game, taking the helm of the Armenian ...